Skolnick P - Search Results

1

Treatment of overdose in the synthetic opioid era.

Skolnick P. Skolnick P. Pharmacol Ther. 2022 May;233:108019. doi: 10.1016/j.pharmthera.2021.108019. Epub 2021 Oct 9. Pharmacol Ther. 2022. PMID: 34637841 Free article. Review.

2

Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.

Krieter P, Chiang N, Gyaw S, Skolnick P, Crystal R, Keegan F, Aker J, Beck M, Harris J. Krieter P, et al. Among authors: skolnick p. J Clin Pharmacol. 2016 Oct;56(10):1243-53. doi: 10.1002/jcph.759. Epub 2016 Jun 10. J Clin Pharmacol. 2016. PMID: 27145977

3

The Opioid Epidemic: Crisis and Solutions.

Skolnick P. Skolnick P. Annu Rev Pharmacol Toxicol. 2018 Jan 6;58:143-159. doi: 10.1146/annurev-pharmtox-010617-052534. Epub 2017 Oct 2. Annu Rev Pharmacol Toxicol. 2018. PMID: 28968188 Review.

4

On the front lines of the opioid epidemic: Rescue by naloxone.

Skolnick P. Skolnick P. Eur J Pharmacol. 2018 Sep 15;835:147-153. doi: 10.1016/j.ejphar.2018.08.004. Epub 2018 Aug 7. Eur J Pharmacol. 2018. PMID: 30092179 Free article.

5

Enhanced Intranasal Absorption of Naltrexone by Dodecyl Maltopyranoside: Implications for the Treatment of Opioid Overdose.

Krieter P, Gyaw S, Chiang CN, Crystal R, Skolnick P. Krieter P, et al. Among authors: skolnick p. J Clin Pharmacol. 2019 Jul;59(7):947-957. doi: 10.1002/jcph.1384. Epub 2019 Jan 30. J Clin Pharmacol. 2019. PMID: 30698833 Free PMC article.

6

Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose.

Krieter P, Gyaw S, Crystal R, Skolnick P. Krieter P, et al. Among authors: skolnick p. J Pharmacol Exp Ther. 2019 Nov;371(2):409-415. doi: 10.1124/jpet.118.256115. Epub 2019 Apr 2. J Pharmacol Exp Ther. 2019. PMID: 30940694 Free PMC article. Clinical Trial.

7

Cannabinoid₁ (CB-1) receptor antagonists: a molecular approach to treating acute cannabinoid overdose.

Skolnick P, Crystal R. Skolnick P, et al. J Neural Transm (Vienna). 2020 Feb;127(2):279-286. doi: 10.1007/s00702-019-02132-7. Epub 2019 Dec 31. J Neural Transm (Vienna). 2020. PMID: 31893308 Free PMC article. Review.

8

Countermeasures for Preventing and Treating Opioid Overdose.

France CP, Ahern GP, Averick S, Disney A, Enright HA, Esmaeli-Azad B, Federico A, Gerak LR, Husbands SM, Kolber B, Lau EY, Lao V, Maguire DR, Malfatti MA, Martinez G, Mayer BP, Pravetoni M, Sahibzada N, Skolnick P, Snyder EY, Tomycz N, Valdez CA, Zapf J. France CP, et al. Among authors: skolnick p. Clin Pharmacol Ther. 2021 Mar;109(3):578-590. doi: 10.1002/cpt.2098. Epub 2020 Nov 29. Clin Pharmacol Ther. 2021. PMID: 33113208 Free PMC article. Review.

9

(2S,4R)-4-methylglutamic acid (SYM 2081): a selective, high-affinity ligand for kainate receptors.

Zhou LM, Gu ZQ, Costa AM, Yamada KA, Mansson PE, Giordano T, Skolnick P, Jones KA. Zhou LM, et al. Among authors: skolnick p. J Pharmacol Exp Ther. 1997 Jan;280(1):422-7. J Pharmacol Exp Ther. 1997. PMID: 8996224

10

Re-energizing the Development of Pain Therapeutics in Light of the Opioid Epidemic.

Skolnick P, Volkow ND. Skolnick P, et al. Neuron. 2016 Oct 19;92(2):294-297. doi: 10.1016/j.neuron.2016.09.051. Neuron. 2016. PMID: 27764663 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

466 results

Search Page